Is Celestica The Best AI Stock to Buy Now?
Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…
Buy
65
PRE Quote, Financials, Valuation and Earnings
Last price:
$17.85
Seasonality move
:
-5%
Day range:
$17.00 - $17.90
52-week range:
$3.09 - $22.86
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
2.65x
P/B ratio:
1.86x
Volume:
178.9K
Avg. volume:
307.6K
1-year change:
244.49%
Market cap:
$299.7M
Revenue:
$92.4M
EPS (TTM):
-$4.11
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
PRE
Prenetics Global Ltd.
|
$33.4M | -$0.52 | 112.14% | -38.67% | $32.33 |
|
CKLSF
CK Life Sciences International (Holdings), Inc.
|
-- | -- | -- | -- | -- |
|
HCM
HUTCHMED (China) Ltd.
|
-- | -- | -- | -- | $21.11 |
|
LJUIF
SSY Group Ltd.
|
-- | -- | -- | -- | -- |
|
SBMFF
Sino Biopharmaceutical Ltd.
|
-- | -- | -- | -- | -- |
|
UNBSF
Uni-Bio Science Group
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
PRE
Prenetics Global Ltd.
|
$17.81 | $32.33 | $299.7M | -- | $0.00 | 0% | 2.65x |
|
CKLSF
CK Life Sciences International (Holdings), Inc.
|
$0.07 | -- | $672.8M | -- | $0.00 | 0% | 0.95x |
|
HCM
HUTCHMED (China) Ltd.
|
$14.72 | $21.11 | $2.5B | 4.92x | $0.00 | 0% | 4.25x |
|
LJUIF
SSY Group Ltd.
|
$0.40 | -- | $1.2B | 14.08x | $0.01 | 4.63% | 2.02x |
|
SBMFF
Sino Biopharmaceutical Ltd.
|
$0.84 | -- | $15B | 30.49x | $0.01 | 1.37% | 3.57x |
|
UNBSF
Uni-Bio Science Group
|
-- | -- | -- | -- | $0.00 | 0% | -- |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
PRE
Prenetics Global Ltd.
|
1% | 5.687 | 0.67% | 2.33x |
|
CKLSF
CK Life Sciences International (Holdings), Inc.
|
-- | 0.000 | -- | -- |
|
HCM
HUTCHMED (China) Ltd.
|
7.07% | 0.259 | -- | 4.41x |
|
LJUIF
SSY Group Ltd.
|
33.22% | -0.277 | -- | 2.03x |
|
SBMFF
Sino Biopharmaceutical Ltd.
|
23.1% | 0.898 | -- | 1.14x |
|
UNBSF
Uni-Bio Science Group
|
-- | 0.000 | -- | -- |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
PRE
Prenetics Global Ltd.
|
$21.7M | -$12.4M | -32.86% | -33.55% | -33.89% | -- |
|
CKLSF
CK Life Sciences International (Holdings), Inc.
|
-- | -- | -- | -- | -- | -- |
|
HCM
HUTCHMED (China) Ltd.
|
-- | -- | 46.32% | 50.64% | -- | -- |
|
LJUIF
SSY Group Ltd.
|
-- | -- | 12.86% | 19.05% | -- | -- |
|
SBMFF
Sino Biopharmaceutical Ltd.
|
-- | -- | 6.83% | 8.57% | -- | -- |
|
UNBSF
Uni-Bio Science Group
|
-- | -- | -- | -- | -- | -- |
Prenetics Global Ltd. vs. Competitors
-
Which has Higher Returns PRE or CKLSF?
CK Life Sciences International (Holdings), Inc. has a net margin of -77.72% compared to Prenetics Global Ltd.'s net margin of --. Prenetics Global Ltd.'s return on equity of -33.55% beat CK Life Sciences International (Holdings), Inc.'s return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital PREPrenetics Global Ltd.59.47% -$1.75 $176.3M CKLSFCK Life Sciences International (Holdings), Inc.-- -- -- -
What do Analysts Say About PRE or CKLSF?
Prenetics Global Ltd. has a consensus price target of $32.33, signalling upside risk potential of 81.55%. On the other hand CK Life Sciences International (Holdings), Inc. has an analysts' consensus of -- which suggests that it could fall by --. Given that Prenetics Global Ltd. has higher upside potential than CK Life Sciences International (Holdings), Inc., analysts believe Prenetics Global Ltd. is more attractive than CK Life Sciences International (Holdings), Inc..
Company Buy Ratings Hold Ratings Sell Ratings PREPrenetics Global Ltd.2 0 0 CKLSFCK Life Sciences International (Holdings), Inc.0 0 0 -
Is PRE or CKLSF More Risky?
Prenetics Global Ltd. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison CK Life Sciences International (Holdings), Inc. has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock PRE or CKLSF?
Prenetics Global Ltd. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. CK Life Sciences International (Holdings), Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Prenetics Global Ltd. pays -- of its earnings as a dividend. CK Life Sciences International (Holdings), Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios PRE or CKLSF?
Prenetics Global Ltd. quarterly revenues are $36.6M, which are larger than CK Life Sciences International (Holdings), Inc. quarterly revenues of --. Prenetics Global Ltd.'s net income of -$28.4M is higher than CK Life Sciences International (Holdings), Inc.'s net income of --. Notably, Prenetics Global Ltd.'s price-to-earnings ratio is -- while CK Life Sciences International (Holdings), Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Prenetics Global Ltd. is 2.65x versus 0.95x for CK Life Sciences International (Holdings), Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income PREPrenetics Global Ltd.2.65x -- $36.6M -$28.4M CKLSFCK Life Sciences International (Holdings), Inc.0.95x -- -- --
-
Which has Higher Returns PRE or HCM?
HUTCHMED (China) Ltd. has a net margin of -77.72% compared to Prenetics Global Ltd.'s net margin of --. Prenetics Global Ltd.'s return on equity of -33.55% beat HUTCHMED (China) Ltd.'s return on equity of 50.64%.
Company Gross Margin Earnings Per Share Invested Capital PREPrenetics Global Ltd.59.47% -$1.75 $176.3M HCMHUTCHMED (China) Ltd.-- -- $1.3B -
What do Analysts Say About PRE or HCM?
Prenetics Global Ltd. has a consensus price target of $32.33, signalling upside risk potential of 81.55%. On the other hand HUTCHMED (China) Ltd. has an analysts' consensus of $21.11 which suggests that it could grow by 43.38%. Given that Prenetics Global Ltd. has higher upside potential than HUTCHMED (China) Ltd., analysts believe Prenetics Global Ltd. is more attractive than HUTCHMED (China) Ltd..
Company Buy Ratings Hold Ratings Sell Ratings PREPrenetics Global Ltd.2 0 0 HCMHUTCHMED (China) Ltd.9 2 1 -
Is PRE or HCM More Risky?
Prenetics Global Ltd. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison HUTCHMED (China) Ltd. has a beta of 0.422, suggesting its less volatile than the S&P 500 by 57.83%.
-
Which is a Better Dividend Stock PRE or HCM?
Prenetics Global Ltd. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. HUTCHMED (China) Ltd. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Prenetics Global Ltd. pays -- of its earnings as a dividend. HUTCHMED (China) Ltd. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios PRE or HCM?
Prenetics Global Ltd. quarterly revenues are $36.6M, which are larger than HUTCHMED (China) Ltd. quarterly revenues of --. Prenetics Global Ltd.'s net income of -$28.4M is higher than HUTCHMED (China) Ltd.'s net income of --. Notably, Prenetics Global Ltd.'s price-to-earnings ratio is -- while HUTCHMED (China) Ltd.'s PE ratio is 4.92x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Prenetics Global Ltd. is 2.65x versus 4.25x for HUTCHMED (China) Ltd.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income PREPrenetics Global Ltd.2.65x -- $36.6M -$28.4M HCMHUTCHMED (China) Ltd.4.25x 4.92x -- --
-
Which has Higher Returns PRE or LJUIF?
SSY Group Ltd. has a net margin of -77.72% compared to Prenetics Global Ltd.'s net margin of --. Prenetics Global Ltd.'s return on equity of -33.55% beat SSY Group Ltd.'s return on equity of 19.05%.
Company Gross Margin Earnings Per Share Invested Capital PREPrenetics Global Ltd.59.47% -$1.75 $176.3M LJUIFSSY Group Ltd.-- -- $1.4B -
What do Analysts Say About PRE or LJUIF?
Prenetics Global Ltd. has a consensus price target of $32.33, signalling upside risk potential of 81.55%. On the other hand SSY Group Ltd. has an analysts' consensus of -- which suggests that it could fall by --. Given that Prenetics Global Ltd. has higher upside potential than SSY Group Ltd., analysts believe Prenetics Global Ltd. is more attractive than SSY Group Ltd..
Company Buy Ratings Hold Ratings Sell Ratings PREPrenetics Global Ltd.2 0 0 LJUIFSSY Group Ltd.0 0 0 -
Is PRE or LJUIF More Risky?
Prenetics Global Ltd. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison SSY Group Ltd. has a beta of 0.039, suggesting its less volatile than the S&P 500 by 96.073%.
-
Which is a Better Dividend Stock PRE or LJUIF?
Prenetics Global Ltd. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. SSY Group Ltd. offers a yield of 4.63% to investors and pays a quarterly dividend of $0.01 per share. Prenetics Global Ltd. pays -- of its earnings as a dividend. SSY Group Ltd. pays out 48.86% of its earnings as a dividend. SSY Group Ltd.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios PRE or LJUIF?
Prenetics Global Ltd. quarterly revenues are $36.6M, which are larger than SSY Group Ltd. quarterly revenues of --. Prenetics Global Ltd.'s net income of -$28.4M is higher than SSY Group Ltd.'s net income of --. Notably, Prenetics Global Ltd.'s price-to-earnings ratio is -- while SSY Group Ltd.'s PE ratio is 14.08x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Prenetics Global Ltd. is 2.65x versus 2.02x for SSY Group Ltd.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income PREPrenetics Global Ltd.2.65x -- $36.6M -$28.4M LJUIFSSY Group Ltd.2.02x 14.08x -- --
-
Which has Higher Returns PRE or SBMFF?
Sino Biopharmaceutical Ltd. has a net margin of -77.72% compared to Prenetics Global Ltd.'s net margin of --. Prenetics Global Ltd.'s return on equity of -33.55% beat Sino Biopharmaceutical Ltd.'s return on equity of 8.57%.
Company Gross Margin Earnings Per Share Invested Capital PREPrenetics Global Ltd.59.47% -$1.75 $176.3M SBMFFSino Biopharmaceutical Ltd.-- -- $7.2B -
What do Analysts Say About PRE or SBMFF?
Prenetics Global Ltd. has a consensus price target of $32.33, signalling upside risk potential of 81.55%. On the other hand Sino Biopharmaceutical Ltd. has an analysts' consensus of -- which suggests that it could fall by --. Given that Prenetics Global Ltd. has higher upside potential than Sino Biopharmaceutical Ltd., analysts believe Prenetics Global Ltd. is more attractive than Sino Biopharmaceutical Ltd..
Company Buy Ratings Hold Ratings Sell Ratings PREPrenetics Global Ltd.2 0 0 SBMFFSino Biopharmaceutical Ltd.0 0 0 -
Is PRE or SBMFF More Risky?
Prenetics Global Ltd. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Sino Biopharmaceutical Ltd. has a beta of 0.733, suggesting its less volatile than the S&P 500 by 26.711%.
-
Which is a Better Dividend Stock PRE or SBMFF?
Prenetics Global Ltd. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Sino Biopharmaceutical Ltd. offers a yield of 1.37% to investors and pays a quarterly dividend of $0.01 per share. Prenetics Global Ltd. pays -- of its earnings as a dividend. Sino Biopharmaceutical Ltd. pays out 65.96% of its earnings as a dividend. Sino Biopharmaceutical Ltd.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios PRE or SBMFF?
Prenetics Global Ltd. quarterly revenues are $36.6M, which are larger than Sino Biopharmaceutical Ltd. quarterly revenues of --. Prenetics Global Ltd.'s net income of -$28.4M is higher than Sino Biopharmaceutical Ltd.'s net income of --. Notably, Prenetics Global Ltd.'s price-to-earnings ratio is -- while Sino Biopharmaceutical Ltd.'s PE ratio is 30.49x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Prenetics Global Ltd. is 2.65x versus 3.57x for Sino Biopharmaceutical Ltd.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income PREPrenetics Global Ltd.2.65x -- $36.6M -$28.4M SBMFFSino Biopharmaceutical Ltd.3.57x 30.49x -- --
-
Which has Higher Returns PRE or UNBSF?
Uni-Bio Science Group has a net margin of -77.72% compared to Prenetics Global Ltd.'s net margin of --. Prenetics Global Ltd.'s return on equity of -33.55% beat Uni-Bio Science Group's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital PREPrenetics Global Ltd.59.47% -$1.75 $176.3M UNBSFUni-Bio Science Group-- -- -- -
What do Analysts Say About PRE or UNBSF?
Prenetics Global Ltd. has a consensus price target of $32.33, signalling upside risk potential of 81.55%. On the other hand Uni-Bio Science Group has an analysts' consensus of -- which suggests that it could fall by --. Given that Prenetics Global Ltd. has higher upside potential than Uni-Bio Science Group, analysts believe Prenetics Global Ltd. is more attractive than Uni-Bio Science Group.
Company Buy Ratings Hold Ratings Sell Ratings PREPrenetics Global Ltd.2 0 0 UNBSFUni-Bio Science Group0 0 0 -
Is PRE or UNBSF More Risky?
Prenetics Global Ltd. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Uni-Bio Science Group has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock PRE or UNBSF?
Prenetics Global Ltd. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Uni-Bio Science Group offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Prenetics Global Ltd. pays -- of its earnings as a dividend. Uni-Bio Science Group pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios PRE or UNBSF?
Prenetics Global Ltd. quarterly revenues are $36.6M, which are larger than Uni-Bio Science Group quarterly revenues of --. Prenetics Global Ltd.'s net income of -$28.4M is higher than Uni-Bio Science Group's net income of --. Notably, Prenetics Global Ltd.'s price-to-earnings ratio is -- while Uni-Bio Science Group's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Prenetics Global Ltd. is 2.65x versus -- for Uni-Bio Science Group. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income PREPrenetics Global Ltd.2.65x -- $36.6M -$28.4M UNBSFUni-Bio Science Group-- -- -- --
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will AI Disrupt SaaS Software Stocks?
Since January 28th, software stocks in the United States have…
Why Is Meta Stock Going Higher?
Over the last five days, shares of Instagram and Facebook…
Stock Ideas
Sell
50
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 38x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Sell
37
Is GOOGL Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 28x
Alerts
Buy
59
SEZL alert for Feb 27
Sezzle, Inc. [SEZL] is down 13.96% over the past day.
Buy
83
GCT alert for Feb 27
GigaCloud Technology, Inc. [GCT] is down 10.47% over the past day.
Buy
62
LMAT alert for Feb 27
LeMaitre Vascular, Inc. [LMAT] is down 6.68% over the past day.
